Biliary excretion of olmesartan, an anigotensin II receptor antagonist, in the rat.
OBJECTIVE
Olmesartan (RNH-6270) is a newly developed anigotensin II receptor antagonist, and has been reported to be excreted into feces. To examine the mechanism of the biliary excretion of olmesartan, we studied its biliary excretion in rats.


METHODS
The biliary excretion of olmesartan in Eisai hyperbilirubinemic rats (EHBR), a multidrug resistance protein 2-deficient rat, was compared with control rats, and the effect of organic anions and cation and bile acids on the biliary excretion of olmesartan was studied in control rats.


RESULTS
The biliary excretion of olmesartan was markedly delayed in EHBR. The biliary excretion of olmesartan was inhibited by sulfobromophthalein, cefpiramide and pravastatin, but was not inhibited by taurocholate or tauroursodeoxycholate. Vinblastine inhibited and phenothiazine treatment increased the biliary excretion of olmesartan.


CONCLUSIONS
These findings suggest that olmesartan is excreted into the bile mainly by multidrug resistance protein 2 and partly by P-glycoprotein.
Takayanagi
Motoe
M
Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Sano
Naoyo
N
Takikawa
Hajime
H
D018528:ATP-Binding Cassette Transporters / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000493:pharmacokinetics*; D000818:Animals; D002511:Cephalosporins / Q000494:pharmacology; D003135:Common Bile Duct / Q000187:drug effects / Q000378:metabolism*; D007093:Imidazoles / Q000493:pharmacokinetics*; D008297:Male; D000068557:Olmesartan Medoxomil; D010640:Phenothiazines / Q000494:pharmacology; D017035:Pravastatin / Q000494:pharmacology; D051381:Rats; D011922:Rats, Mutant Strains; D017207:Rats, Sprague-Dawley; D013448:Sulfobromophthalein / Q000494:pharmacology; D013655:Taurochenodeoxycholic Acid / Q000494:pharmacology; D013656:Taurocholic Acid / Q000494:pharmacology; D013777:Tetrazoles / Q000493:pharmacokinetics*; D014747:Vinblastine / Q000494:pharmacology
D018528:ATP-Binding Cassette Transporters; C423013:Abcc2 protein, rat; D047228:Angiotensin II Type 1 Receptor Blockers; D002511:Cephalosporins; D007093:Imidazoles; D010640:Phenothiazines; D013777:Tetrazoles; D013448:Sulfobromophthalein; D013655:Taurochenodeoxycholic Acid; D013656:Taurocholic Acid; D014747:Vinblastine; C031655:ursodoxicoltaurine; D000068557:Olmesartan Medoxomil; C031637:phenothiazine; D017035:Pravastatin; C036666:cefpiramide